ArticleJournal of immunotherapy and precision oncology2026

Impact of Germline BRCA Status on Pathologic Complete Response (pCR) and Outcomes in Early TNBC Treated with Pembrolizumab-Based Neoadjuvant Chemotherapy (KEYNOTE-522 Regimen): A Real-World Study.

Mohammad Aldawoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.